COVID-19 Therapeutic Trials: Investigators Should Join Forces Rather Than Conduct Single Site Studies

‘Treacherous combination’ of small clinical trials, lagging enrollment, unreported results and uncompleted trials is hindering COVID-19 research, former FDA Commissioner Califf says. Yale professor calls for a ‘Manhattan Project’ around knowledge and a change in the academic star system.

COVID therapeutics
Many clinical trials of COVID-19 therapeutics are small and never completed • Source: Alamy

More from Clinical Trials

More from R&D